Stephen T. Worland - Jun 20, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
President and Chief Executive, Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
Stock symbol
EFTR
Transactions as of
Jun 20, 2022
Transactions value $
$0
Form type
4
Date filed
6/22/2022, 04:13 PM
Previous filing
Jun 16, 2022
Next filing
Nov 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +521K $0.00 521K Jun 20, 2022 Common Stock 521K $1.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests 50% on June 20, 2023, and in 12 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.